ÂÜÀòÂÒÂ×

Kerry Hafner is an accomplished biostatistician with extensive experience in leadership roles within the life sciences sector. Currently serving as Senior Vice President of Biostatistics and Senior Vice President Operations at Syneos Health since August 2019, Kerry has previously held senior positions at PRA Health Sciences, Metrodora Therapeutics, and PRA International, managing various aspects of clinical development, biometrics, and data management. With a strong educational background, including a Ph.D. and M.S. in Biostatistics from the University of North Carolina at Chapel Hill and a B.S. in Mathematics from the University of Wisconsin-Stout, Kerry emphasizes innovative strategies and client relationships to drive business success in clinical research and development.